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A study of the association of plasma irisin levels and coronary artery
diseases
Guangqi Chen, Tao Li, Xiaopeng Xu, Wenhui Peng
Department of Cardiology, Shanghai Tenth People’s Hospital, Tongji
University of Medicine, Shanghai, China
OBJECTIVES Irisin is a newly discovered myokine, which is
involved in energy metabolism and associated with ‘browning’ of
the white adipose tissue, obesity, diabetes mellitus and metabolic
syndrome. It’s still uncertain that whether plasma irisin level is
associated with coronary artery diseases(CAD). The purpose of this
study is to explore the relationship between circulating irisin levels
and CAD.
METHODS A total of 209 patients complained with ‘chest discomfort’
undergone coronary angiography were enrolled in this study. They
were divided into non-CAD(n¼74) and CAD (n¼135) groups. The CAD
group was further divided into three groups: SAP (n¼52), UAP (n¼30),
AMI (n¼53). The levels of plasma irisin, clinical parameters, lipid
proﬁle and C reactive protein (CRP) were measured. and echocardi-
ography was performed on enrolled subjects.
RESULTS The levels of plasma irisin were signiﬁcantly higher in the
CAD group (124.1058.56 ng/ml) than those in the non-CAD group
(95.6659.8 ng/ml), p¼0.001. And positively associated with aortic
root diameter (0.181, p¼0.046), left ventricular posterior wall thick-
ness(0.191, p¼0.035), interventricular septum thickness (0.207,
p¼0.022), and multiple linear regression reveal that irisin concentra-
tion is associated with blood uric acid (r¼0.397, p¼0.003), serum
creatinine (r¼-2.239, p¼0.03) independently. The levels of plasma
irisin were signiﬁcantly lower in the SAP group than UAP group
(103.4861.50 ng/mL VS 133.6758.24 ng/mL, P¼0.021) and AMI
group (103.4861.50 ng/mL VS 139.2050.12 ng/mL, P¼0.002). But it
is not signiﬁcantly difference between UAP and AMI group
(133.6758.24 ng/mL VS 139.2050.12 ng/mL, P¼0.671). The plasma
irisin concentration of CAD patients with normal renal function or
abnormal renal function were 125.6959.66 ng/mL, 110.7851.09 ng/
mL (P¼0.33), respectively. After one year of follow up of AMI group
subjects, the data show that the incidence of MACEs is lower in
irisin > median group (32.14%) than irisin < median group(50%).
CONCLUSIONS The plasma irisin concentration is higher in CAD pa-
tients than non CAD subjects, and correlated with aortic root diam-
eter, left ventricular posterior wall thickness, interventricular septum
thickness, blood uric acid, serum creatinine in the CAD patients. And
gradually increasing in the subgroups of CAD(SAP, UAP, AMI). And
lower in patients of CAD with normal renal function than abnormal
renal function. The incidence of MACEs is lower in AMI subjects with
higher irisin levels undergone percutaneous coronary intervention
treatment.GW26-e0387
Thromboelastograph in the clinical application of acute coronary
syndrome
Zhiliang Chen, Lei Wang
Beijing Friendship Hospital
OBJECTIVES The purpose of this study is to clear the relationship
platelet reactivity to adenosine diphosphate by Thromboelastograph
with ischemic events after PCI.
METHODS We measured platelet reactivity to adenosine diphosphate
(ADP) by Thromboelastograph in acute coronary syndrome undergo-
ing PCI (n¼89). All patients take orally clopidogrel with loading dose
of 300 mg, or maintenance dose of 75 mg at least 3 days. According to
the result of Thromboelastograph, We divide the ADP inhibition rate
into the two groups (A group ADP inhibition rate more than 50% and B
group ADP inhibition rate less than 50%), and observe six to nine
months events of the two groups. End point events were deﬁned as
new cardiovascular events (death、myocardial infarction, myocardial
ischemia, peripheral vascular disease) and new cerebrovascular
events (cerebral infarct and hemorrhage).
RESULTS Within six to nine months after discharge, 11 of 22patients
in A group occurred events, including TIA (n¼1), unstable angina
(n¼5), variant angina pectoris (n¼1), NSTEMI(n¼1), STEMI(n¼1), car-
diac insufﬁciency(n¼1). However in B group, there were 19 events that
occurred in 67patients within six to nine months after discharge,
including death(n¼1), cerebral infarction(n¼1), NSTEMI(n¼1), unsta-
ble angina(n¼16). There was signiﬁcant statistical difference between
the two groups on gender, history of high blood pressure, ureanitrogen, platelet inhibition mediated by ADP, AA (arachidonic acid)
of platelet inhibition mediated by AA (arachidonic acid), ADP medi-
ated MA(P¼0.004,P¼0.022,P¼0.029,P¼0,P¼0,P¼0). Logistic regres-
sion analyses revealed that ADP mediated MA is the independent
predict factors of the occurrence of major cardiovascular and cere-
brovascular events (P¼0.029 ).
CONCLUSIONS All data shows that ADP mediated platelet MA value
can guidance antiplatelet therapy in patients at risk of acute coronary
syndrome, so as to reduce the incidence of end point events.
GW26-e0397
Impact of rhBNP on reperfusion injury in the patients with acute
myocardial infarction undergoing emergency percutaneous coronary
intervention
Lijun Wang
Department of Cardiology, Afﬁliated Zhongshan hospital of Dalian
University
OBJECTIVES To investigate the effect of Lyophiluzed Recombinant
Human Brain Natriuretic Peptide (rhBNP) on myocardiac reperfusion
injury in the patients with ST-segment elevation myocardial infarc-
tion (STEMI) of anterior wall undergoing emergency percutaneous
coronary intervention (PCI).
METHODS This prospective study included patients with acute STEMI
of anterior wall undergoing emergency PCI hospitalized at Afﬁliated
Zhongshan hospital of Dalian University from January 2013 to October
2014. Patientswith SBP< 100mmHg, culprit vessel blood ﬂowof TIMI 2-
3 before PCI, and renal insufﬁciency were excluded. 60 patients were
randomly divided into rhBNP group (n ¼ 29) and control group (n ¼ 31).
In the rhBNP group, rhBNP was injected by intravenous with 1.5 ug/kg
between 3minutes and 5minutes followed with continuous infusion of
0.01ug-1.min-1, and the totle dose of rhBNP was 0.5g in each patient.
Other procedures of rhBNP group were similar with those of control
group. Patients’ demographic, clinical and angiographic characteristics
were obtained. The supemxide dismutase (SOD), malonaldehyde
(MDA) were measured. The parameters presentingmyocardial infusion
including corrected TIMI framecount (CTFC) and myocardial blush
grade (MBG) were calculated. The reperfusion arrhythmias was recor-
ded. Left ventricular ejection fraction (LVEF) of the recruited patients
was assessed at 3-5 days and 6 weeks after emergency PCI.
RESULTS The serum level of MDA signiﬁcantly lower(5.521.21
vs.6.721.22, p<0.05), and serum SOD level was signiﬁcantly higher in
rhBNP group than those in control group (84.93.5214.28
vs.73.9213.71, p<0.05). Compared with control group, CTFC was
signiﬁcantly lower in rhBNP group (24.233.65 vs. 26.973.28,
p<0.05). The MBG  grade 2 was more common(86.21% vs. 61.29%,
p <0.05), and incidence of reperfusion arrhythmias was less common
in rhBNP group than those in control (all p<0.05). RhBNP group pa-
tients’ LVEF was higher than that in control group at both 3 days and 6
weeks after emergency PCI (53.829.26 vs. 51.4510.12 and
55.1211.54 vs. 52.1713.03 respectively, all p<0.05). No signiﬁcant
differences including age, gender, hypertension, diabetes, hyperlip-
idemia, history of previous myocardial infaction, blood pressure and
heart rate before PCI, time from onset to balloon, diseased vessel
number and culprit lesion site were observed between the two groups.
CONCLUSIONS RhBNP can effectively reduce myocardial ischemia-
reperfusion injury in patients with STEMI of anterior wall after
emergency PCI.
GW26-e0501
Characteristics of coagulation-anticoagulation-ﬁbrinolytic system related
gene mRNA expression in patients with acute myocardial infarction and
stable angina pectoris
Chuanrong Li, Lemin Wang
Department of Cardiology, Tongji Hospital, Tongji University School of
Medicine, Shanghai, China
OBJECTIVES The objective of this study was to investigate expres-
sion differences of coagulation -anticoagulation - ﬁbrinolytic system
related genes mRNA among acute myocardial infarction (AMI), stable
angina pectoris (SAP) and control groups, and then analyze system-
atically their dynamic trends in myocardial ischemia as well as arterial
thrombosis.
METHODS WholeHumanGenomeOligoMicroarrayswereappliedtoassess
the differential expression characteristics of coagulation -anticoagulation -
ﬁbrinolytic system relatedmRNAs in patients with AMI (n¼20), SAP (n¼20)
and controls (n¼20).
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mRNAs related to coagulant factors (FGB, F5, F8 and F13) was
obviously elevated (P<0.05) in patients with CAD, and the expres-
sion of 2 mRNAs (F5 and F8) among 14 genes was signiﬁcantly up-
regulated (P<0.01) in the AMI groups. (2) In AMI group, the
expression of all mRNAs related to anticoagulant factors was higher
than SAP and control groups, especially, the expression of 3
mRNA(TFPI THBD and SERPINA1) among 8 gens was signiﬁcantly
up-regulated (P<0.01). (3) Compared with control group, the
expression of 3 ﬁbrolysis factor-related mRNAs (SERPINE1 PLAU
and PLAUR) was signiﬁcantly up-regulated (P<0.01) in both groups
AMI and SAP. PLAT mRNA expression was not obviously elevated
and PLG mRNA expression was down-regulated in AMI and SAP
groups.
CONCLUSIONS In this study, there were imbalances in the expression
of mRNAs among coagulation, anticoagulation and ﬁbrinolysis: the
expression of many mRNAs related to coagulant factors and antico-
agulant factors was signiﬁcantly up-regulated, and the expression of
mRNAs related to ﬁbrinolytic system was disordered.
This disequilibrium plays an important role in the progression of
coronary artery disease and arterial thrombosis.GW26-e1456
The Clinical Characteristics, Treatment Status and Their Relations to
Prognosis among Patients Admitted to Tertiary A TCM hospital for Acute
Myocardial Infarction
Xin Hu, Hongxu Liu
Beijing Hospital of Traditional Chinese Medicine, Capital Medical
University
OBJECTIVES To improve clinical quality and patient outcomes in
tertiary A TCM hospitals by providing evidence-base ﬁndings which
obtained through investigation done on patients’ characteristics,
treatments status and prognosis among patients admitted for AMI
during 2013.
METHODS This research is done through analysis of all AMI in-patient
medical records sampled from 29 participated TCM hospitals based on
the diagnosis and treatments guideline for MI issued by Chinese
Medical Association. Cases data were obtain through standardized
CRF that looks into patients’ clinical characteristics, treatment and
prognosis. Data were managed with Microsoft SQL Server. We adopted
descriptive analysis method on general information with SPSS 15.0,
while logistic regression method was employed to conduct multi-
plicity analysis on their related prognosis. Statistical signiﬁcant was
deﬁned as P0.05.
RESULTS Total of 1217 AMI patients were reported to be admitted by
the 29 hospitals which agreed to participate in this research from 1st,
Jan to 31st Dec, 2013. Mean age of the sampled patients was
65.4812.96 years old, among which, 52.42% were over 65 years old,
357(29.55%) were female. 402 patients (34.04%) has been smoking
regularly while 225 (19.50%) has been regular drinker; 61.16%,
32.00% and 34.63% were reported to be associated with HTN, DM
and hyperlipidemia respectively. 439 patients (37.91%) had historical
diagnosis of CHD, 136(12.18%) had MI; 218 patients (18.59%) had
CVD. Meanwhile, 686 cases (59.04%) of STEMI patients were found
among all studied patients; 291 cases (24.87%) were diagnosed with
arrhythmias on admission. The rate of patients with in-hospital
Killip classiﬁcation I, II, III, IV was 54.15%, 23.50%, 8.79%, 7.97%
separately. The most frequently occurred TCM syndromes type of
deﬁcient were: heart-QI deﬁciency (62.37%), heart-YIN deﬁciency
(19.15%), spleen& kidney-QI deﬁciency (10.19%). 1053(86.52%) cases
showed symptoms of blood stasis, while 606 (49.80%) showed
characteristics of phlegm and retained ﬂuid. 536(44.04%) patients
underwent early reperfusion treatments. 1101 (90.47%) and 530
(43.55%) of all cases had received Chinese patent drug intravenously
and orally, 741(60.89%) patients had been given TCM decoction
subscriptions. After eliminated interactions effects, our ﬁnding in-
dicates the following factors has signiﬁcant inﬂuences on the death
rate of studied AMI patients: age, history of diabetes, arrhythmia,
Killip classiﬁcation, TCM clinical manifestations of spleen & kidney-
QI deﬁciency or cold coagulation, early revascularization, oral
Chinese patent drug and TCM decoction.
CONCLUSIONS Findings suggested that the risk factors of in-hospital
mortality including: age65 years, previous medical history of dia-
betes or arrhythmia, Killip classiﬁcationI, TCM clinical manifesta-
tions of spleen& kidney-QI deﬁciency or cold coagulation. Meanwhile,
early reperfusion, oral Chinese patent drug and decoction may have
positively improved short-term prognosis of AMI patients.GW26-e2511
The Correlation Analysis between plasma Cystatin C and the prognosis of
patients with STEMI
Pei Sun, Zhuqin Li
Department of Cardiology, The First Afﬁliated Hospital of Harbin
Medical University, Harbin, China
OBJECTIVES In recent years, the mortality of acute ST segment
Elevation Myocardial Infarction (STEMI) has been increased. Early
assessment for prognosis of STEMI patients is very signiﬁcant.
Although there already have some clinical marker for predicting the
prognosis of STEMI, it’s still dissatisﬁed. Preliminary research showed
that Cystatin C (Cys-C) has the independent prediction value for
STEMI. It seems to be that Cys-C might be involved in atherosclerotic
processes. Another study show that Cys-C and its fragments may also
affect the phagocytic and chemotactic ability of neutrophil, partici-
pates in the inﬂammatory process and regulates inﬂammatory re-
sponses. This study aims to analysis the correlation between plasma
Cys-C and the MACE in STEMI patients.
METHODS Hospitalized patients in coronary care unit of the First
Afﬁliated Hospital of Harbin Medical University from January 2012 to
December 2013 are selected. Patients were diagnosed as STEMI. A total
of 445 patients are selected. Observation indicator is the major adverse
cardiovascular events (MACE) occurrence of those patients in-hospital
and out-hospital. Patients are divided MACE group and non- MACE
group. Statistical analysis is performed. ROC curves of Cys-C, hsCRP,
TnI andCKMBare respectively drawn. Thepredictory value ferMACEas
well as to determine the threshold value. According to the concentra-
tion of plasmaCys-C, patients are divided high concentration group and
low concentration group, and respectively statistical analysis for two
group patients, thus evaluating the correlation among plasma Cys-C
level, the prognosis and adverse events of patients with STEMI.
RESULTS 1. The single factor analysis shows that the average value of
Cys-C in the MACE group is 1.09  0.23 mg/L, while in the non-MACE
group it is 0.82  0.15 mg/L, and there is statistical difference between
two groups (P < 0.0001).
2. Multiple factors analysis shows that OR value of Cys-C is 9.710,
95% CI (5.971, 5.971), indicating that Cys-C is an independent risk
factor of AMI.
3. The area under ROC curve of Cys-C is 0.8431, higher than that of
Hs-CRP (0.6249), TNI (0.544) and CK-MB (0.5569). The best cutoff
values that Cys - C predicting the MACE in STEMI patients is 0.94 mg/
L, the sensitivity was 77.14%, speciﬁcity of 80.85%.
4. With terms in-hospital stay, out-hospital in 1w 6 months and in 7
w12 months, in comparison, the incidence of MACE for the higher
concentration group are 57%, 31.64% and 48.57%, and the lower group
are 17.96%, 2.49% and 7.08% separately, P<0.05; and for terms in-
hospital stay, out-hospital within 1 w 6 months and within 7 w12
months, the total mortality of higher concentration group is 11.5%,
30% and 48.5%, and the lower concentration group, 1.63%, 2.04% and
8.89% separately, P<0.05.
CONCLUSIONS There might be some correlation between the Cys-C
and the MACE in STEMI patients. Cys-C is an independent risk factor
and potential prognosis indicator for MACE that happens both in-
hospital and out-hospital in STEMI patients.
GW26-e4568
Mean Platelet Volume is the Predictor of Poor Myocardial Perfusion post
Primary PCI
Jianqiang Xu, Xiangdong Zhao, Chengzhi Lu
Tianjin 1st Central Hospital
OBJECTIVES Mean platelet volume (MPV) is shown to be the pre-
dictor of poor clinical outcome, as well as poor TIMI ﬂow in patients
receiving primary percutaneous coronary intervention (PPCI). But the
correlation of MPV and myocardial perfusion has not been well
demonstrated. So the aim of our study was to investigate the rela-
tionship between pre-intervention MPV and myocardial perfusion
post PPCI in patient with acute ST-segment elevation myocardial
infarction (STEMI).
METHODS Total of 168 consecutive patients from 2012, January to
2014, December suffered from STEMI undergoing PPCI were analyzed
retrospectively. The inclusion criteria were (1) age>65yrs; (2) PPCI was
performed within 12 hours from symptom onset; (3) the infarct-related
artery (IRA) was totally occluded; and (4) post intervention ﬂow was
TIMI 2 or greater. Exclusion criteria were (1) post history of myocardial
infarction, CABG or PCI of IRA; (2) presentation with shock or cardiac
arrest; (3) TIMI 1 or greater ﬂow at IRA at initial angiography; and
